V717F؉/؊ transgenic mice expressing mouse apoE, no apoE, or human apoE2, apoE3, or apoE4 demonstrate that apoE facilitates, but is not required for, A␤ fibril formation in vivo. Human apoE isoforms markedly delayed A␤ deposition relative to mouse apoE, with apoE2 (and apoE3 to a lesser extent) having a prolonged ability to prevent A␤ from converting into fibrillar forms. Isoform-specific effects of human apoE on A␤ levels and neuritic plaque formation mimicked that observed in AD (E4 > E3 > E2). Importantly, observation of an apoE-dependent decrease in percent soluble A␤ and enrichment of A␤ in membrane microdomains prior to A␤ deposition indicates that apoE influences A␤ metabolism early in the amyloidogenic process and provides a possible novel mechanism by which apoE affects AD pathogenesis. © 2002 Elsevier Science (USA)
Deposition of amyloid-␤ (A␤) peptides in amyloid plaques is an early pathologic event that likely occurs many years prior to clinical signs of Alzheimer's disease (AD) (Price and Morris, 1999) . Genetic epidemiologic studies have shown that the ⑀4 allele of apolipoprotein E (apoE) is a strong risk factor for AD (Strittmatter et al., 1993; Saunders et al., 1993) , whereas the ⑀2 allele appears to be protective (Corder et al., 1994; West et al., 1994) . ApoE4 is associated with an earlier age of onset of AD (Corder et al., 1993) and an increased amyloid plaque burden in those who die with the disease (Rebeck et al., 1993; Schmechel et al., 1993) . Substantial evidence suggests that interactions between apoE and A␤ are critical for the development of A␤-associated pathology (Wisniewski et al., 1997) , the most compelling of which comes from studies of transgenic mouse models of AD (for reviews, see Fagan and Holtzman, 2000; Teter, 2000) . APP V717F and APP SW transgenic mice expressing a mutant form of the human amyloid precursor protein (APP) predominantly in CNS neurons develop age-dependent A␤ deposition and amyloid plaque-associated neuritic dystrophy (Bales et al., 1997; Holtzman et al., 2000a Holtzman et al., , 2000b . When bred to a mouse apoEϪ/Ϫ background, these mice display significant reductions in A␤ deposition, and in APP V717F mice, an altered anatomic distribution of A␤ deposits. Importantly, in mice analyzed to date, these A␤ deposits are thioflavine-Snegative, indicating nonfibrillar, "diffuse" plaques that do not contain dystrophic neurites (Bales et al., 1997 (Bales et al., , 1999 Irizarry et al., 2000; Holtzman et al., 2000a) . These results suggest that apoE is required for the conversion of A␤ from a soluble form to a pathologic/ toxic form(s) with high ␤-sheet content.
Surprisingly, expression of human apoE3 or apoE4 in APP V717F , apoE Ϫ/Ϫ mice has been reported to markedly suppress A␤ deposition in young animals (9
